Systemic Lupus Erythematosus (SLE)
Showing 51 - 60 of 76 posts
https://www.coltonconsortium.org/publications/organ-injury-in-systemic-autoimmunity-is-mediated-by-stem-like-cd8-t-cells-arising-from-tissue-draining-lymph-nodes/
https://www.coltonconsortium.org/publications/extrarenal-symptoms-associate-with-worse-quality-of-life-in-patients-enrolled-in-the-amp-ra-sle-lupus-nephritis-network/
https://www.coltonconsortium.org/publications/a-lupus-derived-autoantibody-that-binds-to-intracellular-rna-activates-cgas-mediated-tumor-immunity-and-can-deliver-rna-into-cells/
https://www.coltonconsortium.org/publications/a-retrospective-evaluation-of-glucagon-like-peptide-1-receptor-agonists-in-systemic-lupus-erythematosus-patients/
https://www.coltonconsortium.org/publications/association-of-autoantibody-concentrations-and-trajectories-with-lupus-nephritis-histologic-features-and-treatment-response/
https://www.coltonconsortium.org/publications/associations-between-blood-dna-methylation-and-histopathologic-features-in-lupus-nephritis/
https://www.coltonconsortium.org/publications/blood-immunophenotyping-identifies-distinct-kidney-histopathology-and-outcomes-in-patients-with-lupus-nephritis/
https://www.coltonconsortium.org/publications/chimeric-antigen-receptor-t-cells-against-the-ighv4-34-b-cell-receptor-specifically-eliminate-neoplastic-and-autoimmune-b-cells/
https://www.coltonconsortium.org/news/yale-researchers-identify-two-new-therapeutic-targets-for-fibrotic-diseases-like-scleroderma-and-lupus/
Two Yale studies have identified a promising new antibody therapy and a previously unknown signaling pathway as potential treatments for fibrotic autoimmune diseases including scleroderma, lupus, and graft-versus-host disease.
https://www.coltonconsortium.org/news/colton-consortium-sponsors-2025-faseb-autoimmunity-conference/
The Colton Consortium sponsored the 2025 FASEB Autoimmunity Conference in Niagara Falls, a leading international forum dedicated to advancing autoimmune research and fostering collaboration among scientists and clinicians worldwide.
